The kickass science and technology radio show that delivers an irreverent look at the week in science and technology.
…
continue reading
Content provided by American Lung Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Lung Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Stopping Lung Cancer Before It Starts with Drs. Steven Dubinett & Avrum Spira
MP3•Episode home
Manage episode 425420280 series 3310605
Content provided by American Lung Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Lung Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Episode Highlights
0:15 Intro
3:39 Update in pre-lung cancer genome atlas research
17:06 Next steps: applying innovations in bronchoscopy
21:45 When we can anticipate results
25:05 Understanding the lung’s microbiome
29:21 Utility of fragmentomics
31:01 Outro
Dr. Steven Dubinett at University of California, Los Angeles and Dr. Avrum Spira at Boston University revisit our virtual studio to provide an update on their lung cancer interception research, as currently funded by the American Lung Association and LUNGevity Foundation. With the goal of combating cancer at a preliminary stage, Drs. Dubinett and Spira are focused on refining molecular and imaging markers to help identify high-risk premalignant lesions. These findings hope to lead to future therapeutics halting the progression of cells likely to cause invasive cancer.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
0:15 Intro
3:39 Update in pre-lung cancer genome atlas research
17:06 Next steps: applying innovations in bronchoscopy
21:45 When we can anticipate results
25:05 Understanding the lung’s microbiome
29:21 Utility of fragmentomics
31:01 Outro
Dr. Steven Dubinett at University of California, Los Angeles and Dr. Avrum Spira at Boston University revisit our virtual studio to provide an update on their lung cancer interception research, as currently funded by the American Lung Association and LUNGevity Foundation. With the goal of combating cancer at a preliminary stage, Drs. Dubinett and Spira are focused on refining molecular and imaging markers to help identify high-risk premalignant lesions. These findings hope to lead to future therapeutics halting the progression of cells likely to cause invasive cancer.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
52 episodes
MP3•Episode home
Manage episode 425420280 series 3310605
Content provided by American Lung Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Lung Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Episode Highlights
0:15 Intro
3:39 Update in pre-lung cancer genome atlas research
17:06 Next steps: applying innovations in bronchoscopy
21:45 When we can anticipate results
25:05 Understanding the lung’s microbiome
29:21 Utility of fragmentomics
31:01 Outro
Dr. Steven Dubinett at University of California, Los Angeles and Dr. Avrum Spira at Boston University revisit our virtual studio to provide an update on their lung cancer interception research, as currently funded by the American Lung Association and LUNGevity Foundation. With the goal of combating cancer at a preliminary stage, Drs. Dubinett and Spira are focused on refining molecular and imaging markers to help identify high-risk premalignant lesions. These findings hope to lead to future therapeutics halting the progression of cells likely to cause invasive cancer.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
0:15 Intro
3:39 Update in pre-lung cancer genome atlas research
17:06 Next steps: applying innovations in bronchoscopy
21:45 When we can anticipate results
25:05 Understanding the lung’s microbiome
29:21 Utility of fragmentomics
31:01 Outro
Dr. Steven Dubinett at University of California, Los Angeles and Dr. Avrum Spira at Boston University revisit our virtual studio to provide an update on their lung cancer interception research, as currently funded by the American Lung Association and LUNGevity Foundation. With the goal of combating cancer at a preliminary stage, Drs. Dubinett and Spira are focused on refining molecular and imaging markers to help identify high-risk premalignant lesions. These findings hope to lead to future therapeutics halting the progression of cells likely to cause invasive cancer.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
52 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.